Fractyl Health (GUTS) Accounts Payables (2023 - 2026)
Fractyl Health (GUTS) reported Accounts Payables of $1.6 million for Q1 2026, up 11.49% year-on-year from $1.5 million in Q1 2025, and down 85.85% quarter-over-quarter from $11.7 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Accounts Payables data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 11.49% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 11.49% YoY), and the FY2025 full-year result was $11.7 million, up 0.62% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.6 million, down from $11.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $12.4 million in Q3 2025 and bottomed at $1.5 million in Q1 2025.
- A 4-year average of $6.7 million and a median of $7.2 million in 2023 frame the typical range for Accounts Payables.
- Peak annual rise in Accounts Payables reached 599.15% in 2025, while the deepest fall reached 82.91% in 2025.
- Tracing GUTS's Accounts Payables over 4 years: stood at $7.3 million in 2023, then surged by 57.95% to $11.6 million in 2024, then rose by 0.62% to $11.7 million in 2025, then plunged by 85.85% to $1.6 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.6 million, $11.7 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 12.35 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 11.58 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 7.11 Mn |
| Mar 31, 2024 | 8.65 Mn |
| Dec 31, 2023 | 7.33 Mn |